improvement in fev1 produced in the laboratory by the metered dose inhaler with spacer device was significantly greater than by metered dose inhaler alone ( p less than 0.001 ) and similar to that from the nebuliser in both asthmatic groups throughout a range of terbutaline doses .
C0004096
asthmatic
C0039542
terbutaline